CHM vs ALA
CDH 17 licence announced July 2021 , IND granted 10 / 11 2023, trial opened May 2024
ALA's iNKT licence announced June 2021 ( back then SUD ), no IND or trial start
ALA's iNKT IL-12 ?????????????
IMU decided it is not worth to continue the co-op with ALA, so maybe ALA's iNKT is not to be expected to become the world's best liquid cancer CAR-T
ALA valued AUD 120m, CHM valued $20 including GBM and AML trials and FDA requests to advance this 2 to rego trials.
Who is right? The ALA investors or the CHM " deniers "?
GLTA
- Forums
- ASX - By Stock
- CHM
- Ann: Chimeric opens CHM CDH17 Phase 1/2 trial
Ann: Chimeric opens CHM CDH17 Phase 1/2 trial, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $15.76M |
Open | High | Low | Value | Volume |
1.6¢ | 1.8¢ | 1.6¢ | $22.38K | 1.331M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19425 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 249425 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19425 | 0.017 |
14 | 3872701 | 0.016 |
13 | 4573398 | 0.015 |
6 | 2361428 | 0.014 |
2 | 400000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 249425 | 2 |
0.019 | 449959 | 4 |
0.020 | 779755 | 3 |
0.021 | 488333 | 3 |
0.022 | 560000 | 3 |
Last trade - 15.32pm 11/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |